BusinessIP veteran Andrew Filler joins BioSig Technologies’ Board of DirectorsBy Nasdaq OMXNov 10, 2017, 1:00 PM UTC
BusinessMyriad Collaborates with Department of Veterans Affairs in Large Trial Evaluating the GeneSight® Test to Improve Mental Health Outcomes for VeteransBy Nasdaq OMXNov 10, 2017, 12:05 PM UTC
BusinessLifeVantage Announces Financial Results for the First Quarter of Fiscal 2018By Nasdaq OMXNov 8, 2017, 9:07 PM UTC
BusinessTerrestrial Energy IMSR First Commercial Advanced Reactor Assessed by RegulatorBy Nasdaq OMXNov 8, 2017, 2:01 PM UTC
BusinessBioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28By Nasdaq OMXNov 8, 2017, 1:00 PM UTC
BusinessGenesis Electronics Group Inc. (OTC-Pink:"GEGI") sister company of (OTC-Pink:"QEDN") CEO Provides Corporate UpdateBy Nasdaq OMXNov 7, 2017, 4:40 PM UTC
BusinessMyriad Genetics Collaborates with CareFirst BlueCross BlueShield on Coverage with Evidence Development (CED) Study for the Vectra® DA TestBy Nasdaq OMXNov 6, 2017, 12:05 PM UTC
BusinessMyriad Announces GeneSight® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive DisorderBy Nasdaq OMXNov 2, 2017, 11:05 AM UTC
